C008 Basic Self-Assessment of Dermatopathology Discussion
DESCRIPTION
Prior to this session, participants will have reviewed 60 digitally-scanned slides representing common and uncommon skin diseases, both neoplastic and inflammatory. Diagnoses (and differential diagnoses) will be reviewed and discussed by faculty.
**Attendees Please Note**
This year, participants will be responsible for completing the slide review portion prior to the discussion session. You will be emailed instructions for accessing the digital slides the week prior to the review session. The discussion handouts will be sent via email the day of the review session. This activity has been approved by the American Board of Dermatology (ABD) for up to 60 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org
LEARNING OBJECTIVES
Identify histopathologic findings of skin diseases more effectively.
Diagnose common and uncommon skin diseases through microscopic evaluation.
SCHEDULE
9:00 AM
Introduction
Travis W Vandergriff, MD, FAAD
9:08 AM
Cases 1-5
Thomas L. Davis, MD, FAAD
9:22 AM
Cases 6-10
Tammie C. Ferringer, MD, FAAD
9:36 AM
Cases 11-15
Sara Shalin, MD, PhD
9:50 AM
Cases 16-20
Adnan Mir, MD, PhD, FAAD
10:04 AM
Cases 21-25
Jeffrey P. North, MD, FAAD
10:18 AM
Cases 26-30
Antoanella Calame, MD, FAAD
10:32 AM
Cases 31-35
Olayemi Sokumbi, MD, FAAD
10:46 AM
Cases 36-40
Whitney A. High, MD, JD, FAAD
11:00 AM
Cases 41-45
Kara Elisabeth Young, MD, FAAD
11:14 AM
Cases 46-50
Leslie Robinson-Bostom, MD, FAAD
11:28 AM
Cases 51-55
Catherine Chung, MD, FAAD
11:42 AM
Cases 56-60
Kiran Motaparthi, MD, FAAD
DIRECTOR
Travis W Vandergriff, MD, FAAD
SPEAKERS
Antoanella Calame, MD, FAAD
Catherine Chung, MD, FAAD
Thomas L. Davis, MD, FAAD
Tammie C. Ferringer, MD, FAAD
Whitney A. High, MD, JD, FAAD
Adnan Mir, MD, PhD, FAAD
Kiran Motaparthi, MD, FAAD
Jeffrey P. North, MD, FAAD
Leslie Robinson-Bostom, MD, FAAD
Sara Shalin, MD, PhD
Olayemi Sokumbi, MD, FAAD
Kara Elisabeth Young, MD, FAAD
DISCLOSURES
Antoanella Calame, MD, FAAD
No financial relationships exist with ineligible companies.
Catherine Chung, MD, FAAD
No financial relationships exist with ineligible companies.
Thomas L. Davis, MD, FAAD
No financial relationships exist with ineligible companies.
Tammie C. Ferringer, MD, FAAD
No financial relationships exist with ineligible companies.
Whitney A. High, MD, JD, FAAD
No financial relationships exist with ineligible companies.
Adnan Mir, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Kiran Motaparthi, MD, FAAD
Castle Biosciences, Inc – Consultant(Fees), Investigator(Grants/Research Funding); Proscia – Investigator(Grants/Research Funding);
Jeffrey P. North, MD, FAAD
Johnson & Johnson Pharmaceutical Research & Development – Consultant (1099 relationship)(Fees);
Leslie Robinson-Bostom, MD, FAAD
No financial relationships exist with ineligible companies.
Sara Shalin, MD, PhD
No financial relationships exist with ineligible companies.
Olayemi Sokumbi, MD, FAAD
No financial relationships exist with ineligible companies.
Travis W Vandergriff, MD, FAAD
Elsevier Inc. – Independent Contractor(Honoraria);
Kara Elisabeth Young, MD, FAAD
3Derm Systems – Investigator(No Compensation Received);